#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphoma Congenital megacolon Subarachnoid haemorrhage Peripheral T-cell lymphoma unspecified Fragile X syndrome Glycogen storage disease type V Thalassaemia beta Clear cell papillary renal cell carcinoma NTRK gene fusion overexpression Ovarian epithelial cancer Osteosarcoma recurrent Follicle centre lymphoma follicular grade I II – III refractory Juvenile idiopathic arthritis Nephrotic syndrome Toxic epidermal necrolysis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Life with Disease Cystic fibrosis lung – Basic Information KBG syndrome – Life with Disease Factor IX deficiency – Treatment Pulmonary sarcoidosis – Diagnostics Ewing’s sarcoma – Basic Information KBG syndrome – Basic Information Mucopolysaccharidosis III – Basic Information Methylmalonic acidaemia – Life with Disease Kearns-Sayre syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iloprost Trometamol Corylus Avellana L. Melphalan Flufenamide Basiliximab Meldonium Pritelivir Eplontersen Dactinomycin Salbutamol ORG-129 GXV813 Etoricoxib Zalunfiban Asfotase Alfa Tofacitinib FERUMOXTRAN-10 Colistin Sulfate Fludrocortisone Meclofenamate Sodium Maralixibat Chloride More therapies…

    Learn about Your Condition

    Perineal injury Incisional hernia Upper limb fracture Hypertension Exudative retinopathy Ligament sprain Laparoscopic surgery Psychotic disorder Small fibre neuropathy Hyperparathyroidism primary Hepatitis B Arterial stiffness Lymphatic malformation Rhabdomyosarcoma Immunodeficiency congenital More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praxis Geseke

Praxis Geseke

Kleiner Hellweg 5, Geseke, 59590, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2

  • Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

    Not recruiting

    2 1
    Investigated Diseases:
    • Vaginal infection
    Investigated Drugs:
    • Lactobacillus Rhamnosus, Strain Lcr35, Live
    France Germany

  • Study on the Effectiveness of Chaste Tree Extract (Vitex agnus-castus BNO 1095) for Women with Menstrual Cramps (Primary Dysmenorrhea)

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dry Extract From Chaste Tree Fruits (7-11:1), Extraction Solvent: Ethanol 70% (V/V)
    Austria Czechia Germany Hungary Poland Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!